Loading…

ResMed completed its acquisition of Propeller Health, a digital therapeutics company for COPD and asthma, for $225 million in cash. Propeller will operate as a standalone business within ResMed's Respiratory Care portfolio.
“I’m excited to welcome Propeller, a fellow digital health innovator and high-performing company, into the ResMed family.”biospace.com
Summarized from public sources; check the original articles before acting on it.